Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Phase 1 Unknown
100 enrolled
OUTREACH
Phase 1 Unknown
75 enrolled
Treating Nectin-4-positive Advanced Breast Cancer with XKDCT293 (Nectin-4-CAR-T)
Phase 1 Unknown
18 enrolled
Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
96 enrolled
Phase I of XKH002 Injection in Patients
Phase 1 Unknown
110 enrolled
A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer
Phase 1 Unknown
9 enrolled
AMT-562 in Patients With Selected Advanced Solid Tumors
Phase 1 Unknown
72 enrolled
The Safety and Dosimetry Study of 177Lu-LNC1003 Injection
Phase 1 Unknown
12 enrolled
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Phase 1 Unknown
24 enrolled
A Study of HY-0102 in Patients With Advanced Solid Tumors
Phase 1 Unknown
50 enrolled
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
Phase 1 Unknown
24 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
U87 CART in Treatment of Advanced Solid Tumor
Phase 1 Unknown
12 enrolled
A Phase Ib/â…¡ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer
Phase 1 Unknown
42 enrolled
A Study to Investigate the Safety, Tolerability and Efficacy of HLX60 Combination With HLX10 in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
20 enrolled
A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma
Phase 1 Unknown
11 enrolled
Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects
Phase 1 Unknown
72 enrolled
Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.
Phase 1 Unknown
78 enrolled
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Phase 1 Unknown
71 enrolled
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors
Phase 1 Unknown
12 enrolled
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
Phase 1 Unknown
25 enrolled
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Phase 1 Unknown
50 enrolled
A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
Phase 1 Unknown
140 enrolled
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Phase 1 Unknown
12 enrolled
A Clinical Study of MIL93 in Solid Tumors.
Phase 1 Unknown
228 enrolled
177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors
Phase 1 Unknown
9 enrolled
A Phase 1 Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of EU103 in Advanced or Metastatic Solid Tumors That Have Failed Standard Therapy
Phase 1 Unknown
15 enrolled
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients
Phase 1 Unknown
210 enrolled
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
Phase 1 Unknown
68 enrolled
MK-3475-E90
Phase 1 Unknown
54 enrolled
TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
Phase 1 Unknown
92 enrolled
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
Phase 1 Unknown
90 enrolled
A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies
Phase 1 Unknown
48 enrolled
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Phase 1 Unknown
30 enrolled
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
Phase 1 Unknown
93 enrolled
A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions
Phase 1 Unknown
5 enrolled
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
Phase 1 Unknown
15 enrolled
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the Recurrent Glioblastoma
Phase 1 Unknown
16 enrolled
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Phase 1 Unknown
30 enrolled
F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma
Phase 1 Unknown
55 enrolled
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
Phase 1 Unknown
36 enrolled
RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome
Phase 1 Unknown
112 enrolled
PBF-1129 in Patients With NSCLC
Phase 1 Unknown
18 enrolled
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Phase 1 Unknown
42 enrolled
A Study of ICP-033 in Patients With Advanced Solid Tumors
Phase 1 Unknown
60 enrolled
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Phase 1 Unknown
499 enrolled
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
Phase 1 Unknown
198 enrolled
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
Phase 1 Unknown
17 enrolled
A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer
Phase 1 Unknown
24 enrolled
ERK Inhibitor JSI-1187 in Advanced Solid Tumors
Phase 1 Unknown
60 enrolled